AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
AZD1656 in Transplantation with Diabetes tO PromoTe Immune TOleraNce: a single site,
placebo-controlled, double-blind randomised clinical trial of AZD1656 in renal transplant
patients with Type 2 diabetes